Dermal filler in South Korea: what it is and what it does
Filler adds volume where it is injected. What hyaluronic acid filler is, what it can and cannot do, how long it lasts, and the one risk worth understanding.
- Author
- Aesthetics Korea Editorial Team
- Medical review
- Reviewed by 2 doctorsSee methodology
- Published
- 8 September 2026
- Last updated
- 8 September 2026
- Last reviewed
- —6 min read
Short answer
What is dermal filler and what does it actually do?
Dermal filler is a gel injected under the skin to add volume where it is placed — filling a hollow, restoring a contour, or softening a fold. Most filler used in South Korea is hyaluronic acid, which the body breaks down over months and which a doctor can dissolve on purpose with an enzyme called hyaluronidase. It adds volume; it does not tighten skin, resurface it, or relax a muscle.
Key facts
- Technology
- Injectable gel, most often cross-linked hyaluronic acid; regulated in South Korea as a medical device, not a drug
- Purpose
- Adding or restoring volume and softening contours — not skin tightening and not muscle relaxation
- Pain
- Injection discomfort; topical anaesthetic is usual and many products contain lidocaine
- Downtime
- Swelling and bruising at the injection site are common and settle over days
- Sessions
- One session per treated area, repeated when the effect fades
- Results timeline
- Visible immediately, with the final shape apparent once swelling settles
What is dermal filler?
Dermal filler is a gel injected under the skin so that it occupies space. That is the whole mechanism, and holding onto it explains most of what follows: filler works where something is missing, and it does nothing where the problem is something else.
Most filler used in South Korea is hyaluronic acid — a sugar molecule the body already makes, produced for injection and cross-linked so that it holds its shape and lasts longer than the body's own. Different products are cross-linked differently, which is why one filler is firm enough to build a nose bridge and another is soft enough for under the eyes.
An important classification point that changes how you check it: in South Korea, filler is regulated as a medical device, not a drug. Botulinum toxin is a drug. That is why a filler product is looked up on the Ministry of Food and Drug Safety's device portal, and a toxin on its drug portal.
What it does, and what it does not
Filler adds volume. Placed well, it can restore a hollow that has lost fat, support a fold so it creases less deeply, or change a contour — a chin, a nose bridge, a cheek.
What it does not do is more useful to know, because it is where most disappointment comes from:
- It does not tighten skin. That is what the ultrasound and radiofrequency devices claim to do. Adding volume under loose skin fills it; it does not lift it.
- It does not relax a muscle. Lines made by movement — frown lines, crow's feet — are what botulinum toxin addresses. Filler placed against a moving muscle is fighting the muscle.
- It does not improve skin quality. Texture, pores, and tone are a different set of treatments; skin boosters and resurfacing lasers sit there.
- It is not permanent. Hyaluronic acid is broken down by the body. That is a feature as much as a limitation.
The one thing worth understanding about reversibility
Hyaluronic acid filler can be dissolved on purpose. Hyaluronidase is an enzyme that breaks it down, and a doctor can inject it to remove filler that has migrated, over-filled an area, or — far more urgently — blocked a blood vessel.
This matters when you are choosing. Fillers made of other materials, and semi-permanent products marketed as longer-lasting, do not have that exit. Asking "what material is this, and can it be dissolved" is a better question than "how long does it last".
The serious risk, stated plainly
Filler complications are usually minor: swelling, bruising, lumps that settle or can be massaged. The complication that matters is vascular occlusion — filler entering a blood vessel or pressing on one hard enough to cut off supply. It is rare. It is also the reason this page has a diagram.
A 2025 systematic review and meta-analysis of fourteen studies of confirmed occlusion cases found that the glabella (between the eyebrows), the nose, and the nasolabial folds came up most often, because of the vessels running through them and their connections to the vessels supplying the eye. Hyaluronic acid accounted for 61.3% of cases, which the authors read as a reflection of how widely it is used rather than a property of the material — and they note it is the one that can be reversed.
Outcomes in that review: 58.06% of cases recovered completely, 12.9% were left with permanent deficits, and 84.2% of hyaluronic acid cases recovered where hyaluronidase was given. Delay beyond five days was associated with poor outcomes. The authors' conclusion is about technique, anatomy, and speed of recognition — not about avoiding filler.
For a patient, that turns into three practical things: know that pain out of proportion, blanching or mottling of the skin, or any vision change is an emergency and not something to sleep on; ask whether the clinic keeps hyaluronidase and has used it; and know who you call if it happens after you fly home.
What happens in a Korean clinic
A consultation should establish what is actually being addressed and whether filler is the right tool for it. Numbing cream is usual, and many products contain lidocaine. The injection itself takes minutes per area. Swelling and bruising are normal and settle over days; the final shape is what you see after that, not on the day.
Questions to ask before you agree
- Which product, and what is its Korean name? Look it up on the device portal.
- What material is it, and can it be dissolved?
- How much is being used, and in which areas?
- Who is injecting — and are they a doctor?
- Do you keep hyaluronidase on site?
- What do I do, and who do I contact, if something is wrong after I have left South Korea?
The bottom line
Dermal filler adds volume where it is injected and does nothing else — not tightening, not muscle relaxation, not skin quality. Hyaluronic acid, the type most used in South Korea, is temporary and can be dissolved with hyaluronidase, which is the strongest argument for choosing it. The serious risk is vascular occlusion, concentrated in the glabella, nose, and nasolabial folds, and what protects you is an injector who knows the anatomy, a clinic that keeps the antidote, and knowing that sudden pain or a vision change is an emergency.
Frequently asked questions
- Is filler the same as botox?
- No, and they are not interchangeable. Filler is a gel that occupies space, so it works where volume is missing. Botulinum toxin is a drug that relaxes a muscle, so it works on lines a muscle creates. In South Korea they are even regulated differently: filler as a medical device, botulinum toxin as a drug.
- Can filler be removed if I do not like the result?
- Hyaluronic acid filler can be dissolved with hyaluronidase, an enzyme that breaks it down. That reversibility is the main practical argument for hyaluronic acid over fillers made of other materials, which cannot simply be undone. Ask which material is being used before you agree.
- How long does it last?
- Hyaluronic acid filler is broken down by the body over months, and how long a given product lasts depends on the product, the area, and the person. We are not putting a number on this page until we can attach one to a source that says it for a specific product.
- What is the serious risk?
- Vascular occlusion — filler entering or compressing a blood vessel. It is rare, but it can cause skin necrosis and, if it affects vessels connected to the eye, vision loss. The systematic review cited below found the glabella, nose, and nasolabial folds involved most often, and found that treatment delayed beyond five days was associated with permanent deficits.
- What should I ask the clinic?
- Which product, in which area, and how much. Whether the doctor keeps hyaluronidase on site and has used it. What happens if you develop pain, blanching, or vision change after you leave — and who you contact if that happens after you have flown home.
- How do I know the product is approved in South Korea?
- Ask for the Korean product name in writing and look it up on the Ministry of Food and Drug Safety's device portal. Filler is licensed as a medical device in South Korea, so it appears there rather than on the drug portal.
Medical evidence
- Systematic review2025Risk Factor Analysis for Vascular Occlusions After Dermal Filler Injections: A Systematic Review and Meta-Analysis
"Findings underscore the importance of proper injection technique, detailed anatomical knowledge, and prompt recognition of vascular compromise to reduce the risk of serious complications such as tissue necrosis or vision loss."
Sources
Listed in the order they are used. Source class follows the methodology.
- 1.Risk Factor Analysis for Vascular Occlusions After Dermal Filler Injections: A Systematic Review and Meta-Analysis, Cureus 2025;17(4):e82800 (Chakhachiro & Waseem)Peer-reviewed researchaccessed 2026-09-08Fourteen studies of confirmed vascular occlusion after filler. Glabella, nose and nasolabial folds carried the highest rates; hyaluronic acid accounted for 61.3% of cases, which the authors attribute to how widely it is used rather than to the material. 58.06% recovered completely, 12.9% had permanent deficits, and 84.2% of hyaluronic acid cases recovered where hyaluronidase was given. Delay beyond five days was associated with poor outcomes.
- 2.의료기기 안심책방 (MFDS medical device information portal), Ministry of Food and Drug SafetyGovernment / public bodyaccessed 2026-09-08Where a filler product's Korean licence is looked up. Fillers are licensed as devices, not drugs.
- 3.의약품안전나라 (Drug Safety Korea), Ministry of Food and Drug SafetyGovernment / public bodyaccessed 2026-09-08The drug portal, by contrast — where botulinum toxin products appear. Cited for the device/drug distinction.
- 4.대한피부과의사회 — 피부과 전문의 구별법, Korean Academy of DermatologyProfessional bodyaccessed 2026-09-08The association's public guidance on what board certification in dermatology requires and how a patient can check it. Cited for what the qualification means, not for any treatment claim.